805 related articles for article (PubMed ID: 15300847)
1. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutations.
Clarke LA; Nelson PV; Warrington CL; Morris CP; Hopwood JJ; Scott HS
Hum Mutat; 1994; 3(3):275-82. PubMed ID: 8019563
[TBL] [Abstract][Full Text] [Related]
4. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
[TBL] [Abstract][Full Text] [Related]
5. alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype.
Scott HS; Litjens T; Nelson PV; Brooks DA; Hopwood JJ; Morris CP
Hum Mutat; 1992; 1(4):333-9. PubMed ID: 1301941
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations.
Beesley CE; Meaney CA; Greenland G; Adams V; Vellodi A; Young EP; Winchester BG
Hum Genet; 2001 Nov; 109(5):503-11. PubMed ID: 11735025
[TBL] [Abstract][Full Text] [Related]
7. A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype.
Scott HS; Litjens T; Hopwood JJ; Morris CP
Hum Mutat; 1992; 1(2):103-8. PubMed ID: 1301196
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of mucopolysaccharidosis type VI patients undergoing a trial of enzyme replacement therapy.
Karageorgos L; Harmatz P; Simon J; Pollard A; Clements PR; Brooks DA; Hopwood JJ
Hum Mutat; 2004 Mar; 23(3):229-33. PubMed ID: 14974081
[TBL] [Abstract][Full Text] [Related]
9. A homology model for human alpha-l-iduronidase: insights into human disease.
Rempel BP; Clarke LA; Withers SG
Mol Genet Metab; 2005 May; 85(1):28-37. PubMed ID: 15862278
[TBL] [Abstract][Full Text] [Related]
10. [A novel mutation of the alpha-L-iduronidase gene in a patient with mucopolysaccharidosis type I].
Dou W; Peng C; Zheng JK; Gu XF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):136-9. PubMed ID: 17407067
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
[TBL] [Abstract][Full Text] [Related]
12. Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy.
Pereira VG; Martins AM; Micheletti C; D'Almeida V
Clin Chim Acta; 2008 Jan; 387(1-2):75-9. PubMed ID: 17920576
[TBL] [Abstract][Full Text] [Related]
13. [Mucopolysaccharidosis type I: identification of alpha-L-iduronidase mutations in Tunisian families].
Chkioua L; Khedhiri S; Jaidane Z; Ferchichi S; Habib S; Froissart R; Bonnet V; Chaabouni M; Dandana A; Jrad T; Limem H; Maire I; Abdelhedi M; Laradi S
Arch Pediatr; 2007 Oct; 14(10):1183-9. PubMed ID: 17728118
[TBL] [Abstract][Full Text] [Related]
14. Four novel mutations underlying mild or intermediate forms of alpha-L-iduronidase deficiency (MPS IS and MPS IH/S).
Tieu PT; Bach G; Matynia A; Hwang M; Neufeld EF
Hum Mutat; 1995; 6(1):55-9. PubMed ID: 7550232
[TBL] [Abstract][Full Text] [Related]
15. A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants.
Bremer S; Ohlsson A; Brodtkorb E; Rootwelt H; Rootwelt T; Woldseth B; Mørkrid L
Mol Genet Metab; 2011 Nov; 104(3):289-94. PubMed ID: 21831683
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of mucopolysaccharidosis type I: mutation analysis among the patients of the former Soviet Union.
Voskoboeva EY; Krasnopolskaya XD; Mirenburg TV; Weber B; Hopwood JJ
Mol Genet Metab; 1998 Oct; 65(2):174-80. PubMed ID: 9787109
[TBL] [Abstract][Full Text] [Related]
17. Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of alpha-l-iduronidase mutations causing mucopolysaccharidosis type I.
Kasper DC; Iqbal F; Dvorakova L; Zeman J; Magner M; Bodamer O; Pollak A; Herkner KR; Item CB
Clin Chim Acta; 2010 Mar; 411(5-6):345-50. PubMed ID: 19954743
[TBL] [Abstract][Full Text] [Related]
18. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
19. [Mutation analysis of 11 Chinese patients with attenuated mucopolysaccharidosis type].
WANG XN; SHI HP; ZHANG WM; QIU ZQ; MENG Y; YAO FX; WEI M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):147-51. PubMed ID: 21462124
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations.
Venturi N; Rovelli A; Parini R; Menni F; Brambillasca F; Bertagnolio F; Uziel G; Gatti R; Filocamo M; Donati MA; Biondi A; Goldwurm S
Hum Mutat; 2002 Sep; 20(3):231. PubMed ID: 12203999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
